Björn Wiman

9.6k total citations · 4 hit papers
92 papers, 8.0k citations indexed

About

Björn Wiman is a scholar working on Cancer Research, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Björn Wiman has authored 92 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cancer Research, 32 papers in Hematology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Björn Wiman's work include Protease and Inhibitor Mechanisms (53 papers), Blood Coagulation and Thrombosis Mechanisms (28 papers) and Blood properties and coagulation (25 papers). Björn Wiman is often cited by papers focused on Protease and Inhibitor Mechanisms (53 papers), Blood Coagulation and Thrombosis Mechanisms (28 papers) and Blood properties and coagulation (25 papers). Björn Wiman collaborates with scholars based in Sweden, United Kingdom and United States. Björn Wiman's co-authors include Anders Hamsten, Margareta Blombäck, Ulf dé Fairé, Per Wallén, Mats Rånby, D Collen, U de Faire, Christian Landou, Gösta Dahlén and Göran Walldius and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Björn Wiman

90 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

1987 1.3k citations Anders Hamsten, Margareta Blombäck et al. profile →
Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction

1985 1.1k citations Anders Hamsten, Björn Wiman et al. profile →
Association of Apolipoprotein E Genotypes With Lipid Levels and Coronary Risk

2007 610 citations Anna M. Bennet, Björn Wiman et al. profile →
Evidence for a rapid inhibitor to tissue plasminogen activator in plasma

1983 408 citations Joanna Chmielewska, Mats Rånby et al. Thrombosis Research profile →

Peers

Björn Wiman

HEMAT

PRM

CCM

José A. Páramo Spain

Paul F. Bray United States

Bonno N. Bouma Netherlands

Vicente Vicente Spain

Sol Sherry United States

Paolo Gresele Italy

Uwe Schönbeck United States

Elliot S. Barnathan United States

Marlys L. Koschinsky Canada

Louis M. Fink United States

José A. Páramo Spain

Björn Wiman

1.4k ×0.4

1.6k ×0.6

HEMAT

1.1k ×0.5

PRM

1.3k ×0.9

CCM

1.1k ×0.7

Citations per year, relative to Björn Wiman Björn Wiman (= 1×) peers José A. Páramo

Countries citing papers authored by Björn Wiman

Since Specialization

Citations

This map shows the geographic impact of Björn Wiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Wiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Wiman more than expected).

Fields of papers citing papers by Björn Wiman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Wiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Wiman. The network helps show where Björn Wiman may publish in the future.

Co-authorship network of co-authors of Björn Wiman

This figure shows the co-authorship network connecting the top 25 collaborators of Björn Wiman. A scholar is included among the top collaborators of Björn Wiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Wiman. Björn Wiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Holmström, Margareta, et al.. (2010). A new method measuring the interaction between von Willebrand factor and coagulation factor VIII. Thrombosis Research. 127(1). 47–50.

Wiman, Björn, et al.. (2007). Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity. Blood Coagulation & Fibrinolysis. 18(7). 657–660. 22 indexed citations

Bennet, Anna M., Marta E. Alarcón‐Riquelme, Björn Wiman, Ulf dé Fairé, & Ludmila Prokunina‐Olsson. (2006). Decreased Risk for Myocardial Infarction and Lower Tumor Necrosis Factor–α Levels in Carriers of Variants of the PDCD1 Gene. Human Immunology. 67(9). 700–705. 13 indexed citations

Wang, Haiyao, et al.. (2006). The interaction between plasminogen and antiplasmin variants as studied by surface plasmon resonance. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1764(11). 1730–1734. 7 indexed citations

Katzov, Hagit, Anna M. Bennet, Patrick G. Kehoe, et al.. (2004). A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity. Human Molecular Genetics. 13(21). 2647–2657. 42 indexed citations

Prokunina‐Olsson, Ludmila, Leonid Padyukov, Anna M. Bennet, et al.. (2004). Association of the PD‐1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis & Rheumatism. 50(6). 1770–1773. 138 indexed citations

Held, Claes, Paul Hjemdahl, N. Håkan Wallén, et al.. (2000). Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Atherosclerosis. 148(1). 179–188. 44 indexed citations

Wiman, Björn. (2000). THE FIBRINOLYTIC ENZYME SYSTEM. Hematology/Oncology Clinics of North America. 14(2). 325–338. 17 indexed citations

Seddighzadeh, Maria, Jian‐Nian Zhou, Ulrike Kronenwett, et al.. (1999). ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation. Clinical & Experimental Metastasis. 17(8). 649–654. 36 indexed citations

10.

Sui, Guangchao, et al.. (1999). The role of His143 for the pH-dependent stability of plasminogen activator inhibitor-1. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1434(1). 58–63. 8 indexed citations

11.

Bergman, Ann‐Charlotte, Kazuyasu Sakaguchi, Margareta Sten-Linder, et al.. (1997). Increased expression of α‐enolase in c‐jun transformed rat fibroblasts without increased activation of plasminogen. FEBS Letters. 417(1). 17–20. 13 indexed citations

12.

Wiman, Björn. (1996). Plasminogen activator inhibitor 1 in thrombotic disease. Current Opinion in Hematology. 3(5). 372–378. 14 indexed citations

13.

Winnerkvist, Anders, Björn Wiman, Guro Valen, & Jarle Vaage. (1996). Release of tissue plasminogen activator during reperfusion after different times of ischaemia in isolated, perfused rat hearts. Thrombosis Research. 82(6). 533–542. 13 indexed citations

14.

Humphries, Steve E., Fiona R. Green, Anne Temple, et al.. (1992). Genetic factors determining thrombosis and fibrinolysis. Annals of Epidemiology. 2(4). 371–385. 16 indexed citations

15.

Wiman, Björn, et al.. (1992). Two types of receptors for human plasminogen on group G streptococci. Apmis. 100(1-6). 21–28. 36 indexed citations

16.

Sigurðardóttir, Ólöf & Björn Wiman. (1990). Complex formation between plasminogen activator inhibitor 1 and vitronectin in purified systems and in plasma. Biochimica et Biophysica Acta (BBA) - General Subjects. 1035(1). 56–61. 21 indexed citations

17.

Lindahl, Tomas & Björn Wiman. (1989). Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 994(3). 253–257. 24 indexed citations

18.

Hamsten, Anders, et al.. (1987). Comparison of plasminogen activator inhibitor activity and antigen in plasma samples. Clinica Chimica Acta. 169(2-3). 189–196. 33 indexed citations

19.

Chmielewska, Joanna, Mats Rånby, & Björn Wiman. (1983). Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thrombosis Research. 31(3). 427–436. 408 indexed citations breakdown →

20.

Murano, Genesio, Björn Wiman, Margareta Blombäck, & Birger Blombäck. (1971). Preparation and isolation of the S‐carboxymethyl derivative chains of human fibrinogen. FEBS Letters. 14(1). 37–41. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact